Figure 2.
Twelve-month cumulative incidence of VTE in cancer patients receiving systemic therapy during the first 4 months after cancer diagnosis.
Twelve-month cumulative incidence of VTE in cancer patients receiving systemic therapy during the first 4 months after cancer diagnosis.